A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

Bente Glintborg,Dorte Dalsgaard Pedersen,Kathrine Lederballe Grøn,Dorte Vendelbo Jensen,Hanne Lindegaard,Inge Juul Sørensen,Jimmi Sloth Olsen,Michael Veedfald Sørensen,Jolanta Grydehøj,Salome Kristensen,Anne Gitte Loft,Mette Klarlund,Henrik Nordin,Natalia Manilo,Asta Linauskas,Lis Smedegaard Andersen,Stavros Chrysidis,Lars Pedersen,Inger Marie Jensen Hansen,Jakob Espesen,Oliver Hendricks,Niels Steen Krogh,Sabine Sparre Dieperink,Merete Lund Hetland

doi:10.1136/annrheumdis-2016-210742

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

Bente Glintborg, Dorte Dalsgaard Pedersen + Show 22 more

https://doi.org/10.1136/annrheumdis-2016-210742

Copy DOI

Journal: Annals of the Rheumatic Diseases	Publication Date: May 4, 2017
Citations: 213

Affiliation: Glostrup Hospital, Rigshospitalet, Regionshospitalet Viborg, Gentofte Hospital, Odense University Hospital, University of Copenhagen, Regionshospitalet Silkeborg, Regional Hospital Horsens, Regional Hospital Holstebro, Aalborg University Hospital, Aarhus University Hospital, Zealand University Hospital Køge, Frederiksberg Hospital, North Denmark Region, Svendborg Sygehus, Vejle Sygehus, Kong Christian X's Gigthospital

#Historic Cohort #Ankylosing Spondylitis Disease Activity Score + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

ObjectivesAccording to guidelines, a nationwide non-medical switch from originator (INX, Remicade) to biosimilar infliximab (Remsima, CT-P13) was conducted in Danish patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of the Rheumatic Diseases

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.